Does LOPINAVIR Cause Neoplasm malignant? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Neoplasm malignant have been filed in association with LOPINAVIR (Kaletra). This represents 0.4% of all adverse event reports for LOPINAVIR.
5
Reports of Neoplasm malignant with LOPINAVIR
0.4%
of all LOPINAVIR reports
0
Deaths
1
Hospitalizations
How Dangerous Is Neoplasm malignant From LOPINAVIR?
Of the 5 reports, 1 (20.0%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LOPINAVIR. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does LOPINAVIR Cause?
Foetal exposure during pregnancy (244)
Exposure during pregnancy (184)
Virologic failure (170)
Drug resistance (134)
Off label use (133)
Lipodystrophy acquired (126)
Premature baby (107)
Diplopia (89)
Treatment failure (89)
Premature delivery (88)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which LOPINAVIR Alternatives Have Lower Neoplasm malignant Risk?
LOPINAVIR vs LOPINAVIR\RITONAVIR
LOPINAVIR vs LOPRAZOLAM
LOPINAVIR vs LORATADINE
LOPINAVIR vs LORATADINE\PSEUDOEPHEDRINE
LOPINAVIR vs LORAZEPAM